Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

TYPHOID VI POLYSACCHARIDE VACCINE, PRESER

Awarded
SPE2DP26F8879Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

Defense Logistics Agency Troop Support Medical Supply Chain awarded delivery order SPE2DP26F8879 to DMS Pharmaceutical Group Inc for the procurement of 1,000 units of Typhoid VI Polysaccharide Vaccine, preservative-free. The total contract price is $79,360.00, with a unit price of $79.36. This order is issued under the base admin contract SPE2DX25D9900, which was originally awarded on April 2, 2025. The vaccines, identified by NDC 49281-0790-51 and NSN 6505015334962, are destined for the USS Theodore Roosevelt (CVN 71) with a required delivery date of August 10, 2026. The contract specifies FOB Destination terms, requiring the contractor to handle freight costs and risks until the product reaches the vessel. Shipping must be conducted via the fastest traceable means, and the use of parcel post is strictly prohibited. Inspection and acceptance are performed by the government at the destination. Administrative oversight is managed by the DLA in Philadelphia, with payment processed through the Defense Finance and Accounting Service in Columbus, Ohio. The agreement incorporates standard federal regulations, including FAR 52.222-50 regarding Combating Trafficking in Persons.

General Info

DMS Pharmaceutical Group will supply 1,000 Typhoid vaccines to USS Theodore Roosevelt for $79,360.

Contract Value

$79,360

NAICS

325414 - Biological Product (except Diagnostic) Manufacturing

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

2

SPE2DX-25-D-9900 - Award for Commercial Items

PDF, High priority: read this firstaward
High

SPEZD-26-F-8879 - Order for Supplies or Services

PDF, Low prioritytask-order-award
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseAwarded
Posted

Award Notice

Awarded

Contract was awarded

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Defense Logistics Agency
ContactsNo contacts available
OfficeUSA
Office AddressUSA
ContactsNo contact information available

Full Description

Show more
DLA award SPE2DP26F8879 posted on DIBBS. Awardee: DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) Total Contract Price: $79,360.00 Award Date: 08-10-2026 Delivery order under: SPE2DX25D9900 Line items: - TYPHOID VI POLYSACCHARIDE VACCINE, PRESER (NSN/Part 6505015334962, PR 7017824278)

Similar Contracts

Same NAICS industry code

NAICS: 325414
Federal
Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC)
Solicitation # 12639527R0001
Solicitation 12639527R0001 is a request for proposals issued by the USDA Animal and Plant Health Inspection Service (APHIS) for an Indefinite Delivery Indefinite Quantity (IDIQ) contract. The requirement covers the purchase, storage, and production of Foot and Mouth Disease (FMD) Vaccine Antigen Concentrate (VAC), the conversion of Government-owned VAC into usable finished vaccines, and the direct purchase of finished vaccines. The contract has a ceiling price of 800 million dollars and a long-term performance horizon, featuring five one-year ordering periods starting approximately December 1, 2026, with conversion and delivery of finished vaccines extending through November 30, 2044. The scope of work requires the contractor to produce VAC capable of yielding at least 1.0 million doses and maintain these materials on their premises under strict quality control and temperature standards. Because live FMDV is a Tier 1 Select Agent, the contractor must hold a select agent authorization issued by CDC/APHIS. Finished vaccines must be packaged to maintain temperatures between 2 to 8 degrees Celsius for 24 hours and include electronic temperature monitors. Award will be based on the most advantageous offer considering technical capability, past performance from the last five years, and fair and reasonable pricing. Proposals must be submitted electronically to Stephen Tees by November 10, 2026, at 1700 CT, organized into four separate volumes.
Mrpbs Minneapolis Mn

POSTED

20 days ago

DEADLINE

in 21 days
View Details

More opportunities from Department Of Defense → Defense Logistics Agency

Same awarding agency

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS